Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Subtyping Based on EGFR Mutation-Associated Genes and the Prognostic Role of TRAF2 in Lung Adenocarcinoma.

Human mutation - 1 Jan 2026

Gao Bo, Dong Zihan, Yan Taotao, Liu Zhiwang, Chen Jianle

Abstract excerpt

This study is aimed at systematically identifying key genes associated with EGFR mutations and developing a molecular classification model in lung adenocarcinoma (LUAD) using integrative bioinformatics approaches. Multi-omics datasets derived from cBioPortal and The Cancer Genome Atlas (TCGA) LUAD cohort were interrogated to identify genes correlated with EGFR mutational status. A core set of 18 genes exhibiting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Biomarkers, Tumor
Share to Cell Proliferation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Computational Biology

Share to ErbB Receptors

Share to Gene Expression Regulation, Neoplastic

Share to Lung Neoplasms

Share to TNF Receptor-Associated Factor 2

Source

Open in PubMed Open full text

Identifiers

PMID: 42293334
DOI: 10.1155/humu/1664289
PMCID: PMC13254216

Genes

EGFR
TRAF2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Subtyping Based on EGFR Mutation-Associated Genes and the Prognostic Role of TRAF2 in Lung Adenocarcinoma.PMID 42293334Read ↗

Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinomaSemantic proximity Read ↗

Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.Semantic proximity Read ↗

Identification of Key Genes and Clinical Feature Analyses of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.Semantic proximity Read ↗

Comprehensive multi-omics integration uncovers mitochondrial gene signatures for prognosis and personalized therapy in lung adenocarcinoma.Semantic proximity Read ↗

Integrating genetic mutations and expression profiles for survival prediction of lung adenocarcinomaSemantic proximity Read ↗

Development of a novel prognostic score combining clinicopathologic variables, gene expression, and mutation profiles for lung adenocarcinoma.Semantic proximity Read ↗

GASPS: A Multi-Omics Framework for Defining Genomic Aberration-Driven Signatures and Predicting Patient Outcomes in Lung CancerSemantic proximity Read ↗

Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinomaSemantic proximity Read ↗

Identification of FAT4 Mutation as a Prognostic Marker for Overall Survival and Immune Landscape in Lung AdenocarcinomaSemantic proximity Read ↗

Transcriptome‐level discovery of survival‐associated biomarkers and therapy targets in non‐small‐cell lung cancerSemantic proximity Read ↗

A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung AdenocarcinomaSemantic proximity Read ↗

Integrative omics analysis identifies subtypes with therapeutic implications in lung adenocarcinoma harboring KEAP1/NFE2L2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.